Cargando…

Cathepsins and Their Endogenous Inhibitors in Host Defense During Mycobacterium tuberculosis and HIV Infection

The moment a very old bacterial pathogen met a young virus from the 80’s defined the beginning of a tragic syndemic for humanity. Such is the case for the causative agent of tuberculosis and the human immunodeficiency virus (HIV). Syndemic is by definition a convergence of more than one disease resu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anes, Elsa, Azevedo-Pereira, José Miguel, Pires, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371317/ https://www.ncbi.nlm.nih.gov/pubmed/34421929 http://dx.doi.org/10.3389/fimmu.2021.726984

Ejemplares similares

Repurposing Saquinavir for Host-Directed Therapy to Control Mycobacterium Tuberculosis Infection
por: Pires, David, et al.
Publicado: (2021)

Spatial localization of cathepsins: Implications in immune activation and resolution during infections
por: Anes, Elsa, et al.
Publicado: (2022)

Modulation of Cystatin F in Human Macrophages Impacts Cathepsin-Driven Killing of Multidrug-Resistant Mycobacterium tuberculosis
por: Mandal, Manoj, et al.
Publicado: (2023)

Modulation of Cystatin C in Human Macrophages Improves Anti-Mycobacterial Immune Responses to Mycobacterium tuberculosis Infection and Coinfection With HIV
por: Pires, David, et al.
Publicado: (2021)

Liposomal Delivery of Saquinavir to Macrophages Overcomes Cathepsin Blockade by Mycobacterium tuberculosis and Helps Control the Phagosomal Replicative Niches
por: Pires, David, et al.
Publicado: (2023)

Role of Cathepsins in Mycobacterium tuberculosis Survival in Human Macrophages
por: Pires, David, et al.
Publicado: (2016)

ESAT-6 a Major Virulence Factor of Mycobacterium tuberculosis
por: Anes, Elsa, et al.
Publicado: (2023)

Mycobacterium tuberculosis Modulates miR-106b-5p to Control Cathepsin S Expression Resulting in Higher Pathogen Survival and Poor T-Cell Activation
por: Pires, David, et al.
Publicado: (2017)

Lysosomal Cathepsin Release Is Required for NLRP3-Inflammasome Activation by Mycobacterium tuberculosis in Infected Macrophages
por: Amaral, Eduardo P., et al.
Publicado: (2018)

Development of Chitosan Particles Loaded with siRNA for Cystatin C to Control Intracellular Drug-Resistant Mycobacterium tuberculosis
por: Pires, David, et al.
Publicado: (2023)

HIV/Mtb Co-Infection: From the Amplification of Disease Pathogenesis to an “Emerging Syndemic”
por: Azevedo-Pereira, José Miguel, et al.
Publicado: (2023)

Fluoroquinolone Derivatives in the Treatment of Mycobacterium tuberculosis Infection
por: Pais, João Pedro, et al.
Publicado: (2022)

The Roles of Host Noncoding RNAs in Mycobacterium tuberculosis Infection
por: Wei, Li, et al.
Publicado: (2021)

Cell-to-Cell Transmission of HIV-1 and HIV-2 from Infected Macrophages and Dendritic Cells to CD4+ T Lymphocytes
por: Calado, Marta, et al.
Publicado: (2023)

Ion Channel Blockers as Antimicrobial Agents, Efflux Inhibitors, and Enhancers of Macrophage Killing Activity against Drug Resistant Mycobacterium tuberculosis
por: Machado, Diana, et al.
Publicado: (2016)

Characterizing the BCG Induced Macrophage and Neutrophil Mechanisms for Defense Against Mycobacterium tuberculosis
por: Bickett, Thomas E., et al.
Publicado: (2020)

The Roles of Inflammasomes in Host Defense against Mycobacterium tuberculosis
por: Ma, Jialu, et al.
Publicado: (2021)

Mycobacterium tuberculosis Infection-Driven Foamy Macrophages and Their Implications in Tuberculosis Control as Targets for Host-Directed Therapy
por: Shim, Dahee, et al.
Publicado: (2020)

Editorial: Host immune evasion by Mycobacterium tuberculosis: Current updates
por: Habtamu, Meseret, et al.
Publicado: (2022)

Corrigendum: Mycobacterium tuberculosis Infection-Driven Foamy Macrophages and Their Implications in Tuberculosis Control as Targets for Host-Directed Therapy
por: Shim, Dahee, et al.
Publicado: (2020)

Modeling the Mycobacterium tuberculosis Granuloma – the Critical Battlefield in Host Immunity and Disease
por: Guirado, Evelyn, et al.
Publicado: (2013)

Tolerating the Unwelcome Guest; How the Host Withstands Persistent Mycobacterium tuberculosis
por: Olive, Andrew J., et al.
Publicado: (2018)

Autophagy and Host Defense in Nontuberculous Mycobacterial Infection
por: Silwal, Prashanta, et al.
Publicado: (2021)

Macrophage Polarization: Convergence Point Targeted by Mycobacterium Tuberculosis and HIV
por: Lugo-Villarino, Geanncarlo, et al.
Publicado: (2011)

Lipocalin-2 Functions as Inhibitor of Innate Resistance to Mycobacterium tuberculosis
por: Dahl, Sara Louise, et al.
Publicado: (2018)

Ferritin H Deficiency in Myeloid Compartments Dysregulates Host Energy Metabolism and Increases Susceptibility to Mycobacterium tuberculosis Infection
por: Reddy, Vineel P., et al.
Publicado: (2018)

Evidence for the Effect of Vaccination on Host-Pathogen Interactions in a Murine Model of Pulmonary Tuberculosis by Mycobacterium tuberculosis
por: Zatarain-Barrón, Zyanya Lucia, et al.
Publicado: (2020)

The Host Microbiota Contributes to Early Protection Against Lung Colonization by Mycobacterium tuberculosis
por: Dumas, Alexia, et al.
Publicado: (2018)

Analysis of the Phenotype of Mycobacterium tuberculosis-Specific CD4+ T Cells to Discriminate Latent from Active Tuberculosis in HIV-Uninfected and HIV-Infected Individuals
por: Riou, Catherine, et al.
Publicado: (2017)

Regulatory T Cells in Mycobacterium tuberculosis Infection
por: Cardona, Paula, et al.
Publicado: (2019)

HIV Infection Is Associated With Downregulation of BTLA Expression on Mycobacterium tuberculosis-Specific CD4 T Cells in Active Tuberculosis Disease
por: Barham, Morgan S., et al.
Publicado: (2019)

HIV-Infected Patients Developing Tuberculosis Disease Show Early Changes in the Immune Response to Novel Mycobacterium tuberculosis Antigens
por: Meier, Noemi Rebecca, et al.
Publicado: (2021)

Pharmacologic Inhibition of Host Phosphodiesterase-4 Improves Isoniazid-Mediated Clearance of Mycobacterium tuberculosis
por: Subbian, Selvakumar, et al.
Publicado: (2016)

Inhibition of Transglutaminase 2 as a Potential Host-Directed Therapy Against Mycobacterium tuberculosis
por: Palucci, Ivana, et al.
Publicado: (2020)

Cathepsin B modulates lysosomal biogenesis and host defense against Francisella novicida infection
por: Qi, Xiaopeng, et al.
Publicado: (2016)

A Direct Role for the CD1b Endogenous Spacer in the Recognition of a Mycobacterium tuberculosis Antigen by T-Cell Receptors
por: Camacho, Frank, et al.
Publicado: (2020)

Cyclic di-AMP as endogenous adjuvant enhanced BCG-induced trained immunity and protection against Mycobacterium tuberculosis in mice
por: Ning, Huanhuan, et al.
Publicado: (2022)

Pharmacodynamic Monitoring of RO5459072, a Small Molecule Inhibitor of Cathepsin S
por: Theron, Michel, et al.
Publicado: (2017)

Cathepsins and their endogenous inhibitors cystatins: expression and modulation in multiple sclerosis
por: Haves-Zburof, Dana, et al.
Publicado: (2011)

Recombinant BCG With Bacterial Signaling Molecule Cyclic di-AMP as Endogenous Adjuvant Induces Elevated Immune Responses After Mycobacterium tuberculosis Infection
por: Ning, Huanhuan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ot9haue3r37b443t6em8gu286q